SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-021621
Filing Date
2022-06-02
Accepted
2022-06-02 16:30:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A brhc10038391_defa14a.htm DEFA14A 11172
  Complete submission text file 0001140361-22-021621.txt   12392
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34079 | Film No.: 22991233
SIC: 2834 Pharmaceutical Preparations